Reading the tape
NYSE: ZBH
Zimmer Biomet Holdings, Inc.
Healthcare · Medical - Devices
Market Cap
$15.93B
52w High
$108.29
52w Low
$79.83
P/E
21.09
Volume
1.73M
Outstanding Shares
193.46M
Valuation Data Insufficient
The DCF model's fair value estimate is more than 3× the current stock price. This typically indicates unreliable model inputs — such as irregular cash flows or balance sheet distortions — rather than a genuine opportunity, so the valuation is not shown.
Price vs Fundamentals
Why The Stock Is Moving
Likely multiple compressionModerate confidence
1Y Price: -13.44%Revenue (TTM): 9.23%FCF (TTM): 36.08%P/FCF: 0th pct
What changed
The stock fell 13.44% over the last year. Revenue grew 9.23% over the trailing twelve months. Operating margin moved from 17.04% to 15.61%. Free cash flow grew 36.08% over the trailing twelve months.
What the market seems to be pricing
Visible fundamentals weakened far less than the stock price, and the shares now sit around the 0th percentile of their historical P/FCF range. That looks more like a rerating of the multiple than a collapse in the business.
What would invalidate this read
This read changes if operating margin (currently 15.61%) continues to decline, or if revenue growth turns negative. The bull case requires the business to hold its current trajectory.
Company profile
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
CEOIvan Tornos
SectorHealthcare
IndustryMedical - Devices
Employees17,000
IPO dateJul 25, 2001
Valuation
Forward P/E—
EV/EBITDA11.15
Enterprise value$24.73B
Stock splits
Mar 1, 2022↑ Forward
Every 100 shares became 103
Profitability & growth
Revenue growth9.3%
Gross margin70.03%▼13.78%vs FY2024
Operating margin15.61%▼1.17%vs FY2024
ROE5.55%▼23.43%vs FY2024
Analyst consensus
RatingHold
Target price$96.33▲17.00%
18
Buy
21
Hold
3
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 6, 2026
Q3 FY26 · EPS est $2.01 · Revenue est $2.14B
View
Dividends
$0.96/shareQuarterlyDividend Achiever · 13yrSafeZBH pays a dividend with a 1.17% dividend yield, 13 consecutive years of growth, growing at 0.59% annually, covered 7.7× by free cash flow.
Dividend Yield
1.17%
Annual Div / Share
$0.96
5yr CAGR
+0.59%
Doubles every ~117.3yr
Payout Ratio
24.88%
Safe
Dividend Growth Rate
3yr CAGR
+0%
5yr CAGR
+0.59%
10yr CAGR
+0.95%
Dividend Safety
10/10Safe
Dividend History
Annualized dividend cycles per share
YearAnnual DivYoY
2025$0.96+0.0%
2024$0.96+0.0%
2023$0.96+0.0%
2022$0.96+2.2%
2021$0.94+0.7%
2020$0.93+0.0%
2019$0.93+0.0%
Income Projection
Invest
$
Growth rate:
Reinvest dividends
Today
$12/yr
$1/mo
In 5 yrs
$12/yr+3%
$1/mo
In 10 yrs
$12/yr+6%
$1/mo
| Today | In 5 yrs | In 10 yrs |
|---|---|---|
$12/yr $1/mo | $12/yr+3% $1/mo | $12/yr+6% $1/mo |
Yield-on-cost grows from 1.17% → 1.24% over 10yr
Analysis
Dividend Strengths
Dividend Achiever
ZBH has raised its dividend for 13 consecutive years — qualifying as a Dividend Achiever, demonstrating long-term commitment to shareholder income.
Well-covered by free cash flow
The dividend is covered 7.7× by free cash flow, indicating the company generates sufficient cash to sustain and potentially grow the payout without straining its finances.
Risks to Watch
No strong risk signal stands out from the latest period pair.